DAE HWA Pharmaceutical Co. Ltd (067080) — Cash Flow Quality Index
DAE HWA Pharmaceutical Co. Ltd (067080) has a Cash Flow Quality Index of 0.65x as of December 2025. Operating cash flow of ₩2.06 Billion is below net income of ₩3.18 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 067080 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DAE HWA Pharmaceutical Co. Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for DAE HWA Pharmaceutical Co. Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check DAE HWA Pharmaceutical Co. Ltd (067080) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for DAE HWA Pharmaceutical Co. Ltd (2011–2025)
Year-by-year earnings quality comparison for DAE HWA Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see market cap of DAE HWA Pharmaceutical Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.28x | ₩5.43 Billion | ₩1.65 Billion | ▼ -55.5% |
| 2024 | 7.38x | ₩6.13 Billion | ₩829.83 Million | ▲ +12.0% |
| 2022 | 6.59x | ₩8.05 Billion | ₩1.22 Billion | ▲ +23.8% |
| 2021 | 5.32x | ₩10.45 Billion | ₩1.96 Billion | ▲ +136721.3% |
| 2019 | 0.00x | ₩-41.07 Million | ₩10.54 Billion | ▼ -100.2% |
| 2018 | 1.58x | ₩10.49 Billion | ₩6.65 Billion | ▲ +82.4% |
| 2017 | 0.86x | ₩10.94 Billion | ₩12.65 Billion | ▼ -63.3% |
| 2016 | 2.36x | ₩8.79 Billion | ₩3.73 Billion | ▲ +298.6% |
| 2015 | 0.59x | ₩2.43 Billion | ₩4.11 Billion | ▼ -92.7% |
| 2013 | 8.10x | ₩13.57 Billion | ₩1.68 Billion | ▲ +341.9% |
| 2012 | 1.83x | ₩5.77 Billion | ₩3.15 Billion | ▲ +100.9% |
| 2011 | 0.91x | ₩3.43 Billion | ₩3.76 Billion | — |